Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04372914 · ClinicalTrials.gov registry record · NA
Prevention of Oral DNA Damage by Black Raspberries
A NA study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 69
- Enrollment target
NCT04372914 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 69 participants.
The verdict
NCT04372914, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
Study Summary
The purpose of this voluntary research study is to learn about the potential effects that black raspberry (BRB) lozenges may have on reducing the damage caused from cigarette smoke in mouth cells in adult smokers, which may be useful in reducing health risks associated with smoking.
Interventions
- DIETARY_SUPPLEMENT BRB Lozenges
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2021-10-07 |
| Est. Completion | 2024-12-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04372914
The ClinicalTrials.gov registry entry for NCT04372914 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BRB Lozenges is the first listed.
NCT04372914 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04372914 about?
NCT04372914 is a clinical study titled "Prevention of Oral DNA Damage by Black Raspberries". The purpose of this voluntary research study is to learn about the potential effects that black raspberry (BRB) lozenges may have on reducing the damage caused from cigarette smoke in mouth cells in adult smokers, which may be useful in reducing health risks associated with smoking.
What is the current status of trial NCT04372914?
This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2021-10-07. Estimated completion is 2024-12-06.
What interventions are being tested in trial NCT04372914?
The interventions under investigation include: BRB Lozenges (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04372914?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.